Dabigatran (Pradaxa) safety update: assess and monitor kidney functionDabigatran (Pradaxa) safety update: assess and monitor kidney function

Published 2011-12-01 00:00:00

Reference | Erratum

After evaluating international reports of bleeding, the Therapeutic Goods Administration published a Safety Advisory on 3 November 2011 regarding the risk of bleeding in people using dabigatran (Pradaxa).1 This advisory summarises new recommendations now in place for assessing kidney function before starting this medicine and during its use.

The TGA advises that kidney function should be assessed:

  • for all patients before starting dabigatran therapy
  • during treatment when a decline in kidney function is suspected, for example, low blood volume, dehydration and when certain medicines which may affect kidney function are taken at the same time
  • at least once a year in elderly patients (> 75 years) or in patients with moderate kidney impairment (creatinine clearance < 50 mL/min).

Patients with severe kidney impairment (creatinine clearance < 30 mL/min) should not take dabigatran.

Reference

  1. Therapeutic Goods Administration. Dabigatran (Pradaxa) & the risk of bleeding: new recommendations for monitoring kidney function. TGA Safety Advisory, 3 November 2011. http://www.tga.gov.au/safety/alerts-medicine-dabigatran-111103.htm (accessed 3 November 2011).

ERRATUM
Note that in the August 2011 NPS RADAR article 'Dabigatran (Pradaxa) for stroke prevention in patients with non-valvular atrial fibrillation', a typographical error appeared in the margin note on page 6 relating to the age range criteria of who is at risk: '≤ 75' should have read '≥ 75'.

RSS FeedRSS feed

Date published: 2011-12-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.